A first-in-human Phase 1 study of NL-201 in patients with relapsed or refractory cancer.

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Spence, Anne (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date18/02/221/12/24

Keywords

  • Medical oncology
  • Clinical trial